Voximetry is a is an early stage healthcare technology company specializing in commercialization of complex algorithms on high speed Graphic Processing Units (GPUs). Currently focused on radiation transport science and voxel-level dosimetry, Voximetry is pioneering patient-specific treatment planning in advanced stage cancer patients. Voximetry leverages intellectual property developed at the University of Wisconsin - Madison, which has a rich history of fostering successful biotechnology companies.